ED Decision 2019/002/R
(a) Metabolic, nutritional or endocrine dysfunction
Applicants with metabolic, nutritional or endocrine dysfunction should be assessed as unfit. A fit assessment may be considered if the condition is asymptomatic, clinically compensated and stable.
(b) Obesity
Applicants with a Body Mass Index Âł 35 may be assessed as fit only if the excess weight is not likely to interfere with the safe exercise of the applicable licence(s) and the results of a risk assessment, including evaluation of the cardiovascular system and evaluation of the possibility of sleep apnoea, are satisfactory.
(c) Addison’s disease
Applicants with Addison’s disease may be assessed as fit provided that cortisone is carried and available for use whilst exercising the privileges of the applicable licence(s).
(d) Gout
Applicants with acute gout should be assessed as unfit until asymptomatic.
(e) Thyroid dysfunction
Applicants with thyroid disease may be assessed as fit once a stable euthyroid state is attained.
(f) Abnormal glucose metabolism
Glycosuria and abnormal blood glucose levels require investigation. A fit assessment may be considered if normal glucose tolerance is demonstrated (low renal threshold) or impaired glucose tolerance is fully controlled by diet and regularly reviewed.
(g) Diabetes mellitus
Applicants with diabetes mellitus may be assessed as fit. The use of antidiabetic medications that are not likely to cause hypoglycaemia may be acceptable.
EASA AMC2 MED.B.025 outlines fit assessment criteria for metabolic and endocrine conditions, including obesity, Addison's disease, gout, thyroid dysfunction, glucose metabolism, and diabetes mellitus.
* Summary by Aviation.Bot - Always consult the original document for the most accurate information.
Loading collections...